Total Payments
$1,123
2021 Payments
$73.19
Companies
15
Transactions
61
Medicare Patients
2,049
Medicare Billing
$84,525
Payment Breakdown by Category
Food & Beverage$1,084 (96.6%)
Education$38.28 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,084 | 58 | 96.6% |
| Education | $38.28 | 3 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $416.60 | 21 | $0 (2021) |
| Lilly USA, LLC | $120.05 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $113.71 | 6 | $0 (2020) |
| Amgen Inc. | $83.08 | 5 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $80.56 | 5 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $78.12 | 6 | $0 (2021) |
| Radius Health, Inc. | $57.69 | 4 | $0 (2019) |
| PFIZER INC. | $42.64 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $36.45 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $25.74 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $73.19 | 5 | Novo Nordisk Inc ($34.15) |
| 2020 | $85.32 | 5 | Kowa Pharmaceuticals America, Inc. ($32.04) |
| 2019 | $332.87 | 16 | Lilly USA, LLC ($120.05) |
| 2018 | $372.71 | 20 | Novo Nordisk Inc ($185.41) |
| 2017 | $258.41 | 15 | Novo Nordisk Inc ($197.04) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.94 | General |
| Category: Cardiovascular | ||||||
| 07/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 07/21/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Cardiovascular | ||||||
| 05/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
| 02/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular | ||||||
| 12/17/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: Cardiovascular | ||||||
| 06/11/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $19.73 | General |
| Category: Cardiovascular | ||||||
| 03/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: DIABETES | ||||||
| 01/16/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Neuroscience | ||||||
| 12/10/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: DIABETES | ||||||
| 07/31/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2019 | Lilly USA, LLC | — | Education | In-kind items and services | $8.35 | General |
| 07/15/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Endocrinology | ||||||
| 07/09/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Respiratory | ||||||
| 07/02/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: Cardiovascular | ||||||
| 06/13/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.31 | General |
| Category: Cardiovascular | ||||||
| 05/16/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Neuroscience | ||||||
| 05/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: DIABETES | ||||||
| 04/18/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $111.70 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 110 | 124 | $2,397 | $873.53 |
| 2020 | 17 | 1,939 | 3,219 | $338,309 | $83,651 |
Total Patients
2,049
Total Services
3,343
Medicare Billing
$84,525
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2021 | 32 | 43 | $860.00 | $417.53 | 48.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 60 | 61 | $1,037 | $386.40 | 37.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 20 | $500.00 | $69.60 | 13.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 371 | 1,200 | $180,000 | $37,803 | 21.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 354 | 464 | $103,008 | $20,935 | 20.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 175 | 184 | $13,800 | $10,684 | 77.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 32 | 33 | $5,412 | $3,713 | 68.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 173 | 181 | $5,430 | $3,311 | 61.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 23 | 33 | $4,950 | $1,449 | 29.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 71 | 83 | $3,818 | $1,051 | 27.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 241 | 257 | $3,855 | $887.44 | 23.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 14 | 16 | $2,480 | $679.45 | 27.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 23 | 60 | $1,800 | $641.03 | 35.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 51 | 64 | $1,664 | $616.88 | 37.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 28 | 30 | $2,760 | $517.52 | 18.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 277 | 283 | $5,660 | $510.88 | 9.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 38 | 38 | $456.00 | $235.90 | 51.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 39 | 223 | $892.00 | $216.04 | 24.2% |
| 85610 | Blood test, clotting time | Office | 2020 | 12 | 49 | $980.00 | $208.41 | 21.3% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 17 | 21 | $1,344 | $192.38 | 14.3% |
About Dr. John Dawson, M.D
Dr. John Dawson, M.D is a Geriatric Medicine healthcare provider based in Kamuela, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932291978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dawson, M.D has received a total of $1,123 in payments from pharmaceutical and medical device companies, with $73.19 received in 2021. These payments were reported across 61 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,084).
As a Medicare-enrolled provider, Dawson has provided services to 2,049 Medicare beneficiaries, totaling 3,343 services with total Medicare billing of $84,525. Data is available for 2 years (2020–2021), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Kamuela, HI
- Active Since 09/28/2006
- Last Updated 11/15/2011
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1932291978
Products in Payments
- Ozempic (Drug) $200.32
- Tresiba (Drug) $119.31
- TRULICITY (Drug) $111.70
- JARDIANCE (Drug) $98.81
- Victoza (Drug) $89.89
- Livalo (Drug) $78.12
- Tymlos (Biological) $57.69
- FARXIGA (Drug) $52.88
- Aimovig (Biological) $31.33
- CHANTIX (Drug) $29.72
- Prolia (Biological) $28.08
- Repatha (Biological) $23.67
- PRALUENT (Drug) $18.64
- TOUJEO (Drug) $17.81
- MYRBETRIQ (Drug) $16.59
- BRILINTA (Drug) $15.04
- SPIRIVA RESPIMAT (Drug) $14.90
- Vascepa (Drug) $14.78
- ELIQUIS (Drug) $12.94
- LYRICA (Drug) $12.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.